Original BioMedicals Co., Ltd. (TPEX:6483)
Taiwan · Delayed Price · Currency is TWD 12.90
-0.30 (-2.27%)
Sep 8, 2026, 12:54 PM CST
Original BioMedicals Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -102.24 | -101.51 | -75 | -59.66 | -40.28 | -33.88 |
Depreciation & Amortization | 8.94 | 8.83 | 8.4 | 8.74 | 7.94 | 8.64 |
Stock-Based Compensation | 0.05 | 0.15 | 0.77 | 6.72 | 0.34 | - |
Other Operating Activities | 0.12 | 0.05 | -0.05 | - | - | - |
Change in Accounts Receivable | 0.21 | 0.14 | -0.52 | -0.09 | 0.04 | -0.04 |
Change in Accounts Payable | 0.63 | 2.53 | -15.74 | 18.97 | 1.15 | 1.8 |
Change in Other Net Operating Assets | -30.19 | -6.2 | -1.98 | -2.17 | 0.38 | -1.45 |
Operating Cash Flow | -122.49 | -96.01 | -84.11 | -27.5 | -30.42 | -24.93 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -3.11 | -0.95 | -1.84 | -0.31 | -0.47 | -1.92 |
Investment in Securities | 79.83 | 79.75 | 10.06 | -64.87 | 39.92 | -74.85 |
Other Investing Activities | - | - | - | 0.89 | -0.17 | - |
Investing Cash Flow | 76.72 | 78.8 | 8.22 | -64.29 | 39.28 | -76.77 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | -4.33 | -4.26 | -3.85 | -3.35 | -2.95 |
Lease Payments | -4.14 | -4.33 | -4.26 | -3.85 | -3.35 | -2.95 |
Net Debt Issued (Repaid) | -4.14 | -4.33 | -4.26 | -3.85 | -3.35 | -2.95 |
Issuance of Common Stock | 2.78 | 3.94 | 2.92 | 310.34 | - | 105.02 |
Financing Cash Flow | -1.36 | -0.39 | -1.34 | 306.49 | -3.35 | 102.07 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | -47.14 | -17.6 | -77.23 | 214.7 | 5.52 | 0.36 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -125.6 | -96.96 | -85.95 | -27.81 | -30.89 | -26.86 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | - | -25448.29% | - | -64674.42% | -28864.49% | - |
Free Cash Flow Per Share | -1.89 | -1.46 | -1.30 | -0.56 | -0.66 | -0.65 |
Levered Free Cash Flow | -87.44 | -60 | -60.06 | -5.75 | -16.41 | -14.23 |
Unlevered Free Cash Flow | -87.08 | -59.63 | -59.52 | -5.08 | -15.66 | -13.36 |
Free Cash Flow After Leases | -129.74 | -101.29 | -90.21 | -31.66 | -34.23 | -29.81 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.58 | 0.59 | 0.87 | 1.1 | 1.2 | 1.39 |
Change in Working Capital | -29.36 | -3.53 | -18.23 | 16.71 | 1.58 | 0.31 |